Skip to main content
Equibles
FTH logo

FTH · Faeth Therapeutics, Inc. · Investor Relations

Track FTH — free

Use FTH with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research FTH.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
$10.03 -0.62 (-5.82%) At close · Nov 13
Rebalance outlook locked
Market Cap
$259.21M
Shares
25.84M
Volume · Nov 13 1.04M Avg daily vol (3M) 482.56K

Press releases and events scraped from the company’s investor relations website. Past events open our own call or event page when we host one; otherwise listings link to the original source.

Upcoming events

Date Event Type
2026-11-17 00:00 UTC Jefferies Global Healthcare Conference in London Conference

Recent news

Date Headline
2026-11-09 Faeth Reports Positive Preliminary Phase 2 Topline Results from the PIK-201 Trial Evaluating PIKTOR in Combination with Paclitaxel in Patients with Advanced Endometrial Cancer
2026-11-03 Faeth Therapeutics Reports Third Quarter 2026 Financial Results and Operational Updates
2026-08-04 Faeth Therapeutics Reports Second Quarter 2026 Financial Results and Operational Updates
2026-06-15 Sensei Biotherapeutics Announces Name Change to Faeth Therapeutics, Focused on Advancing PIKTOR, an Oral Therapy Targeting One of the Most Frequently Altered Pathways in Cancer
2026-05-15 Sensei Biotherapeutics Reports First Quarter 2026 Financial Results and Provides Corporate Update
2026-03-30 Sensei Biotherapeutics Reports Full Year 2025 Financial Results and Provides Corporate Update
2026-02-18 Sensei Biotherapeutics Announces Acquisition of Faeth Therapeutics and $200 Million Concurrent Private Placement
2025-11-14 Sensei Biotherapeutics Reports Third Quarter 2025 Financial Results

Past events

Date Event Type
2026-11-09 Virtual Event: PIK-201 Phase 2 Data in Advanced Endometrial Cancer Webcast
2026-10-06 Virtual KOL Event: Multi-Nodal Inhibition for the Treatment of Endometrial Cancer Event
2026-09-16 Morgan Stanley 24th Annual Global Healthcare Conference Conference
2026-09-10 Cantor Global Healthcare Conference 2026 Conference
2026-04-16 25th Annual Needham Virtual Healthcare Conference Conference
2026-02-18 Sensei Acquisition of Faeth Therapeutics Webcast

Source: https://investors.senseibio.com/

Key facts CIK 1829802 CUSIP 81728A207 13F (30d) 41 filings 41 filers Visit website Investor relations